Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue

Journal of Virology
Angélique BiancottoIvan Hirsch

Abstract

To design strategies to purge latent reservoirs of human immunodeficiency virus type 1 (HIV-1), we investigated mechanisms by which a non-tumor-promoting phorbol ester, prostratin, inhibits infection of CD4(+) T lymphocytes and at the same time reactivates virus from latency. CD4(+) T lymphocytes from primary blood mononuclear cells (PBMC) and in blocks of human lymphoid tissue were stimulated with prostratin and infected with HIV-1 to investigate the effects of prostratin on cellular susceptibility to the virus. The capacity of prostratin to reactivate HIV from latency was tested in CD4(+) T cells harboring preintegrated and integrated latent provirus. Prostratin stimulated CD4(+) T cells in an aberrant way. It induced expression of the activation markers CD25 and CD69 but inhibited cell cycling. HIV-1 uptake was reduced in prostratin-stimulated CD4(+) T PBMC and tissues in a manner consistent with a downregulation of CD4 and CXCR4 receptors in these systems. At the postentry level, prostratin inhibited completion of reverse transcription of the viral genome in lymphoid tissue. However, prostratin facilitated integration of the reverse-transcribed HIV-1 genome in nondividing CD4(+) T cells and facilitated expression of already...Continue Reading

References

May 29, 1992·Journal of Medicinal Chemistry·K R GustafsonJ A Beutler
Feb 1, 1983·The Journal of Experimental Medicine·T CotnerJ Strominger
Dec 1, 1995·Nature Medicine·S GlushakovaJ Zimmerberg
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·T W ChunA S Fauci
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·M L PennL Margolis
May 26, 1999·The New England Journal of Medicine·L ZhangD D Ho
Jun 8, 1999·The Journal of Experimental Medicine·D UnutmazD R Littman
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·R T DaveyH C Lane
May 1, 2001·Nature Medicine·S L ButlerF D Bushman
Oct 16, 2001·AIDS·F Gondois-ReyI Hirsch
Jul 23, 2002·Journal of Virology·Yael D KorinJerome A Zack
Aug 7, 2002·Journal of Virology·Theodore C PiersonRobert F Siliciano
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Tae-Wook ChunAnthony S Fauci
Sep 23, 2003·Immunity·David G BrooksJerome A Zack

❮ Previous
Next ❯

Citations

Feb 12, 2009·Expert Reviews in Molecular Medicine·Mary-Catherine BowmanDavid M Margolis
Nov 16, 2011·Immunology and Cell Biology·Fiona WightmanSharon R Lewin
Sep 23, 2006·AIDS Research and Human Retroviruses·David WarrilowDavid Harrich
Feb 2, 2012·QJM : Monthly Journal of the Association of Physicians·J P Williams, J Frater
Oct 18, 2011·Current Opinion in Infectious Diseases·John Frater
Apr 2, 2010·Journal of Virology·John C BurnettAdam P Arkin
Jun 28, 2013·Retrovirology·Carine Van LintAlessandro Marcello
Jul 9, 2013·Retrovirology·Samantha J McDonnelBrian G Murphy
Nov 1, 2011·PloS One·Li HuangChin-Ho Chen
Oct 17, 2007·PLoS Pathogens·Xavier ContrerasB Matija Peterlin
Aug 22, 2009·PLoS Pathogens·Jana BlazkovaIvan Hirsch
Jan 1, 2006·Future Virology·Xavier ContrerasB Matija Peterlin
Apr 17, 2014·Viruses·Angela Battistini, Marco Sgarbanti
Jan 8, 2011·Annual Review of Pharmacology and Toxicology·Shailesh K Choudhary, David M Margolis
Jan 19, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Haiyan JiHuanzhang Zhu
Jan 9, 2009·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Hoi Ping Mok, Andrew Lever
Dec 29, 2012·Drug Discovery Today·Sifei Xing, Robert F Siliciano
Jul 7, 2012·Cytokine & Growth Factor Reviews·Anna Lisa RemoliMarco Sgarbanti
Aug 8, 2006·Antiviral Research·Lorianne Stehouwer TurnerEarl E Henderson
Feb 1, 2013·The Journal of General Virology·Chi Ngai ChanBrian J Willett
Apr 9, 2013·Human Vaccines & Immunotherapeutics·Thomas A RasmussenOle S Søgaard
Jun 1, 2014·Biochemical and Biophysical Research Communications·Xiaoli ZhuHuanzhang Zhu
Oct 7, 2016·Folia Microbiologica·Zora MelkovaJosef Bodor
Apr 14, 2016·Scientific Reports·Panpan LuHuanzhang Zhu
May 5, 2017·Journal of Agricultural and Food Chemistry·Xiaoyun ZengShuwen Liu
Jul 4, 2015·Integrative Biology : Quantitative Biosciences From Nano to Macro·Ramesh RamjiKathryn Miller-Jensen
Dec 2, 2017·Scientific Reports·Panpan LuHuanzhang Zhu
Jun 4, 2016·Current Opinion in HIV and AIDS·Gilles DarcisCarine Van Lint
Feb 13, 2018·Oncology Letters·Dalal AlotaibiVenkataswarup Tiriveedhi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.